Drug
Petosemtamab
Petosemtamab: highest development phase Phase 3, developed by Genmab, Merus. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Genmab, Merus
Trials
| Drug | Phase | Indication |
|---|---|---|
| Petosemtamab NCT07702032 | Phase 3 | Left-sided Colorectal Cancer |
| Petosemtamab NCT06496178 | Phase 3 | Head and Neck Squamous Cell Carcinoma |
| Petosemtamab NCT06525220 | Phase 3 | Head and Neck Squamous Cell Carcinoma |
| Petosemtamab NCT07775287 | Phase 3 | Colorectal Cancer |
Latest
No recent events.
Follow Petosemtamab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.